+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oxymetholone"

Fanconi Anemia (FA) - Pipeline Insight, 2025 - Product Thumbnail Image

Fanconi Anemia (FA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Oxymetholone is a synthetic anabolic-androgenic steroid (AAS) used to treat a variety of hematological conditions, including anemia, thalassemia, and myelodysplastic syndrome. It is also used to stimulate red blood cell production in patients with chronic kidney failure. Oxymetholone is a derivative of dihydrotestosterone (DHT) and is structurally similar to testosterone. It is taken orally and is metabolized in the liver. Oxymetholone is a powerful anabolic agent and is used to increase red blood cell production, improve muscle mass, and reduce fatigue. It is also used to treat anemia caused by chemotherapy or radiation therapy. It is not recommended for use in pregnant women or children. The Oxymetholone market is a niche market within the larger hematological drugs market. It is used to treat a variety of hematological conditions, including anemia, thalassemia, and myelodysplastic syndrome. It is also used to stimulate red blood cell production in patients with chronic kidney failure. Some companies in the Oxymetholone market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more